Suppr超能文献

老年评估对非转移性癌症老年患者放疗强度的影响:一项多机构研究

Impact of Geriatric Assessment on Radiotherapy Intensity in Older Patients With Nonmetastatic Cancer: A Multi-institutional Study.

作者信息

Murofushi K N, Kuribayashi S, Ohnishi K, Hayakawa S, Tsuchida K, Inoue Y, Ohkawa A, Ishida T, Machitori Y, Murakami M, Takizawa D, Saito M

机构信息

Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Department of Radiation Oncology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

出版信息

Clin Oncol (R Coll Radiol). 2025 Sep;45:103894. doi: 10.1016/j.clon.2025.103894. Epub 2025 Jun 18.

Abstract

AIMS

This study prospectively investigated an appropriate geriatric assessment tool for predicting the decisions by radiation oncologists to reduce radiotherapy intensity.

MATERIALS AND METHODS

We enrolled patients with nonmetastatic cancer (aged ≥70 years) in this multicenter study. Reduced-intensity radiotherapy implied changes to the irradiation field and/or radiotherapy schedule from the standard based on the primary tumour guidelines. Geriatric assessment was performed by calculating the Geriatric 8 (G8) and Vulnerable Elders Survey (VES-13) scores before radiotherapy and at 3 to 5 and 8 to 16 weeks post radiotherapy. The primary endpoint was to evaluate the correlation between vulnerability, assessed by G8 score, and changes in radiation intensity.

RESULTS

Between November 2020 and February 2022, 317 patients from 13 centres in Japan were included in this study. The median patient age was 77 years (range: 70-90 years). The primary cancer sites were the head and neck and oesophagus, lungs, breasts, pancreas, bladder, uterus, and prostate in 63 and 22, 62, 48, 6, 5, 26, and 85 patients, respectively. Reduced intensity of radiotherapy was administered to 31 patients (10%); planned radiotherapy was completed in 312 patients (98%). High-precision radiotherapy was administered to 199 patients (63%). The treatment policy was modified in 87 patients (27%). Among these, 77 patients (89%) underwent a reduction in the intensity of concurrent chemotherapy. Grade 3 or higher acute adverse events were observed in 48 patients (15%), with 26 (54%) requiring inpatient treatment. Before radiotherapy, vulnerability was found in 201 (63.4%) and 61 (19.2%) patients based on G8 and VES-13 assessments, respectively. A multivariate analysis revealed that a reduction in radiation intensity was significantly associated with vulnerability assessed using the VES-13 score (P = 0.03) but not the G8 score (P = 0.63).

CONCLUSION

Geriatric assessment by the G8 score did not predict a reduction in radiation intensity or incompletion in older patients with cancer.

摘要

目的

本研究前瞻性地调查了一种合适的老年评估工具,用于预测放射肿瘤学家降低放疗强度的决策。

材料与方法

我们在这项多中心研究中纳入了非转移性癌症患者(年龄≥70岁)。降低强度的放疗意味着根据原发性肿瘤指南,照射野和/或放疗计划与标准方案相比有所改变。在放疗前、放疗后3至5周以及8至16周计算老年8项(G8)和脆弱老年人调查(VES - 13)评分,进行老年评估。主要终点是评估通过G8评分评估的脆弱性与放疗强度变化之间的相关性。

结果

在2020年11月至2022年2月期间,来自日本13个中心的317例患者纳入本研究。患者中位年龄为77岁(范围:70 - 90岁)。原发癌部位分别为头颈部、食管、肺、乳腺、胰腺、膀胱、子宫和前列腺者,各有63、22、62、48、6、5、26和85例患者。31例患者(10%)接受了降低强度的放疗;312例患者(98%)完成了计划的放疗。199例患者(63%)接受了高精度放疗。87例患者(27%)的治疗方案进行了修改。其中,77例患者(89%)接受了同步化疗强度的降低。48例患者(15%)观察到3级或更高等级的急性不良事件,其中26例(54%)需要住院治疗。放疗前,根据G8和VES - 13评估,分别有201例(63.4%)和61例(19.2%)患者存在脆弱性。多因素分析显示,放疗强度降低与使用VES - 13评分评估的脆弱性显著相关(P = 0.03),而与G8评分无关(P = 0.63)。

结论

对于老年癌症患者,通过G8评分进行的老年评估并不能预测放疗强度的降低或治疗未完成情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验